Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in Exp Gerontol

Retrieve available abstracts of 71 articles:
HTML format

Single Articles

    August 2021
  1. LI P, Wu Q, Li X, Hu B, et al
    Shenqi Yizhi Granule attenuates Abeta1-42 induced cognitive dysfunction via inhibiting JAK2/STAT3 activated astrocyte reactivity.
    Exp Gerontol. 2021;151:111400.
    PubMed     Abstract available

    July 2021
  2. VASCONCELOS-FILHO FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, et al
    Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis.
    Exp Gerontol. 2021 Jul 30:111502. doi: 10.1016/j.exger.2021.111502.
    PubMed     Abstract available

  3. VATANABE IP, Pedroso RV, Manzine PR, Chagas MHN, et al
    ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Exp Gerontol. 2021;149:111303.
    PubMed     Abstract available

    June 2021
  4. GALLO A, Pillet LE, Verpillot R
    New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids.
    Exp Gerontol. 2021;152:111452.
    PubMed     Abstract available

    May 2021
  5. CEZAR NOC, Aprahamian I, Ansai JH, de Oliveira MPB, et al
    Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Exp Gerontol. 2021;150:111390.
    PubMed     Abstract available

  6. LIU L, Cao J, Huang C, Yuan E, et al
    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse.
    Exp Gerontol. 2021;147:111274.
    PubMed     Abstract available

  7. YANG I, Arthur RA, Zhao L, Clark J, et al
    The oral microbiome and inflammation in mild cognitive impairment.
    Exp Gerontol. 2021;147:111273.
    PubMed     Abstract available

    April 2021
  8. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    PubMed     Abstract available

    March 2021
  9. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    PubMed     Abstract available

  10. PINI L, Wennberg AM
    Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Exp Gerontol. 2021;145:111216.
    PubMed     Abstract available

    February 2021
  11. EGASHIRA R, Umezaki Y, Mizutani S, Obata T, et al
    Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Exp Gerontol. 2021;144:111189.
    PubMed     Abstract available

    January 2021
  12. FERNANDEZ FX, Kaladchibachi S, Negelspach DC
    Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Exp Gerontol. 2021;147:111258.
    PubMed     Abstract available

  13. BLASKO I, Defrancesco M, Oberacher H, Loacker L, et al
    Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease.
    Exp Gerontol. 2021 Jan 28:111264. doi: 10.1016/j.exger.2021.111264.
    PubMed     Abstract available

  14. YAN T, Liu B, Wang N, Liao Z, et al
    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta1-42 induced mouse model of Alzheimer's disease.
    Exp Gerontol. 2021;147:111263.
    PubMed     Abstract available

  15. SOYSAL P, Tan SG, Smith L
    A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
    Exp Gerontol. 2021;146:111248.
    PubMed     Abstract available

  16. AL-HARRASI AM, Iqbal E, Tsamakis K, Lasek J, et al
    Motor signs in Alzheimer's disease and vascular dementia: Detection through natural language processing, co-morbid features and relationship to adverse outcomes.
    Exp Gerontol. 2021 Jan 12:111223. doi: 10.1016/j.exger.2020.111223.
    PubMed     Abstract available

    December 2020
  17. TZEKAKI EE, Papaspyropoulos A, Tsolaki M, Lazarou E, et al
    Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
    Exp Gerontol. 2020 Dec 5:111178. doi: 10.1016/j.exger.2020.111178.
    PubMed     Abstract available

  18. LIU Q, Lei C
    Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Exp Gerontol. 2020;144:111187.
    PubMed     Abstract available

  19. ZHANG J, Wang R
    Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Exp Gerontol. 2020;144:111180.
    PubMed     Abstract available

  20. SCHIMIDT HL, Carrazoni GS, Garcia A, Izquierdo I, et al
    Strength training or green tea prevent memory deficits in a beta-amyloid peptide-mediated Alzheimer's disease model.
    Exp Gerontol. 2020;143:111186.
    PubMed     Abstract available

    September 2020
  21. YADAV J, Verma AK, Garg RK, Ahmad K, et al
    Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease.
    Exp Gerontol. 2020 Sep 26:111092. doi: 10.1016/j.exger.2020.111092.
    PubMed     Abstract available

    August 2020
  22. WANG R, Zhang J
    Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Abeta-induced neurotoxicity by regulating JAK2.
    Exp Gerontol. 2020 Aug 29:111080. doi: 10.1016/j.exger.2020.111080.
    PubMed     Abstract available

    June 2020
  23. FERNANDES A, Tabuas-Pereira M, Duro D, Lima M, et al
    C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia.
    Exp Gerontol. 2020 Jun 16:111004. doi: 10.1016/j.exger.2020.111004.
    PubMed     Abstract available

    April 2020
  24. KIM YJ, Kim SH, Park Y, Park J, et al
    miR-16-5p is upregulated by amyloid beta deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
    Exp Gerontol. 2020 Apr 19:110954. doi: 10.1016/j.exger.2020.110954.
    PubMed     Abstract available

  25. MUNDO IG, Vielma NMP, Lopez MG, Fleury A, et al
    DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease.
    Exp Gerontol. 2020 Apr 16:110951. doi: 10.1016/j.exger.2020.110951.
    PubMed     Abstract available

  26. SCARABINO D, Peconi M, Broggio E, Gambina G, et al
    Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.
    Exp Gerontol. 2020;136:110945.
    PubMed     Abstract available

  27. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Corrigendum to "Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study" [Exp. Gerontol. 131 (2020) 110816].
    Exp Gerontol. 2020 Apr 8:110943. doi: 10.1016/j.exger.2020.110943.

  28. ELSWORTHY RJ, Aldred S
    The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.
    Exp Gerontol. 2020;132:110838.
    PubMed     Abstract available

    March 2020
  29. MOREL E, Armand S, Assal F, Allali G, et al
    Parkinsonian gait in aging: A feature of Alzheimer's pathology?
    Exp Gerontol. 2020 Mar 2:110905. doi: 10.1016/j.exger.2020.110905.
    PubMed     Abstract available

    February 2020
  30. SINGULANI MP, Pereira CPM, Ferreira AFF, Garcia PC, et al
    Impairment of PGC-1alpha-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease.
    Exp Gerontol. 2020 Feb 18:110882. doi: 10.1016/j.exger.2020.110882.
    PubMed     Abstract available

  31. YAN T, Nian T, Wu B, Xiao F, et al
    Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Abeta1-42 mice.
    Exp Gerontol. 2020;130:110802.
    PubMed     Abstract available

  32. LIN X, Chen Y, Zhang P, Chen G, et al
    The potential mechanism of postoperative cognitive dysfunction in older people.
    Exp Gerontol. 2020;130:110791.
    PubMed     Abstract available

    December 2019
  33. ZHAO J, Liu P, Hua L, Yang X, et al
    Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.
    Exp Gerontol. 2019 Dec 21:110813. doi: 10.1016/j.exger.2019.110813.
    PubMed     Abstract available

  34. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study.
    Exp Gerontol. 2019 Dec 17:110816. doi: 10.1016/j.exger.2019.110816.
    PubMed     Abstract available

  35. CAO F, Liu Z, Sun G
    Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-beta induced neurotoxicity by targeting PTEN.
    Exp Gerontol. 2019;130:110814.
    PubMed     Abstract available

    October 2019
  36. ARIANNA V, Sonila A, Sofia P, Alessia G, et al
    Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2019 Oct 21:110754. doi: 10.1016/j.exger.2019.110754.
    PubMed     Abstract available

    August 2019
  37. ALTINOZ MA, Guloksuz S, Schmidt-Kastner R, Kenis G, et al
    Involvement of hemoglobins in the pathophysiology of Alzheimer's disease.
    Exp Gerontol. 2019 Aug 2:110680. doi: 10.1016/j.exger.2019.110680.
    PubMed     Abstract available

    June 2019
  38. ISIK AT, Kocyigit SE, Smith L, Aydin AE, et al
    A comparison of the prevalence of orthostatic hypotension between older patients with Alzheimer's Disease, Lewy body dementia, and without dementia.
    Exp Gerontol. 2019 Jun 4. pii: S0531-5565(19)30202.
    PubMed     Abstract available

    May 2019
  39. PENA-BAUTISTA C, Baquero M, Ferrer I, Hervas D, et al
    Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients.
    Exp Gerontol. 2019 May 19. pii: S0531-5565(19)30198.
    PubMed     Abstract available

    April 2019
  40. JENSEN CS, Bahl JM, Ostergaard LB, Hogh P, et al
    Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
    Exp Gerontol. 2019 Apr 10. pii: S0531-5565(18)30714.
    PubMed     Abstract available

    February 2019
  41. HAYASHI K, Hasegawa Y, Takemoto Y, Cao C, et al
    Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease.
    Exp Gerontol. 2019 Feb 17. pii: S0531-5565(18)30570.
    PubMed     Abstract available

    January 2019
  42. ZENG Q, Siu W, Li L, Jin Y, et al
    Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine.
    Exp Gerontol. 2019 Jan 30. pii: S0531-5565(18)30772.
    PubMed     Abstract available

  43. MURALEVA NA, Stefanova NA, Kolosova NG
    p38 MAPK-dependent alphaB-crystallin phosphorylation in Alzheimer's disease-like pathology in OXYS rats.
    Exp Gerontol. 2019 Jan 18. pii: S0531-5565(18)30613.
    PubMed     Abstract available

    December 2018
  44. ABRAHAM D, Feher J, Scuderi GL, Szabo D, et al
    Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome.
    Exp Gerontol. 2018 Dec 6. pii: S0531-5565(18)30638.
    PubMed     Abstract available

    November 2018
  45. BEAUCHET O, Launay CP, Sekhon H, Montembeault M, et al
    Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study.
    Exp Gerontol. 2018 Nov 14. pii: S0531-5565(18)30586.
    PubMed     Abstract available

  46. RUDNITSKAYA EA, Kozlova TA, Burnyasheva AO, Kolosova NG, et al
    Alterations of hippocampal neurogenesis during development of Alzheimer's disease-like pathology in OXYS rats.
    Exp Gerontol. 2018 Nov 8. pii: S0531-5565(18)30409.
    PubMed     Abstract available

    September 2018
  47. DRYGALSKI K, Fereniec E, Korycinski K, Chomentowski A, et al
    Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
    Exp Gerontol. 2018;113:36-47.

    August 2018
  48. HUTTER-SCHMID B, Humpel C
    Primary mouse brain pericytes isolated from transgenic Alzheimer mice spontaneously differentiate into a CD11b(+) microglial-like cell type in vitro.
    Exp Gerontol. 2018 Aug 9. pii: S0531-5565(18)30435.
    PubMed     Abstract available

    July 2018
  49. TOROSYAN N, Sethanandha C, Grill JD, Dilley ML, et al
    Changes in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Exp Gerontol. 2018;111:118-121.
    PubMed     Abstract available

    June 2018
  50. SHEKHAR S, Yadav Y, Singh AP, Pradhan R, et al
    Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway.
    Exp Gerontol. 2018 Jun 27. pii: S0531-5565(18)30302.
    PubMed     Abstract available

  51. BUFFA R, Mereu E, Putzu P, Mereu RM, et al
    Corrigendum to "Lower lean mass and higher percent fat mass in patients with Alzheimer's disease" [Exp. Gerontol. 58 (2014) 30-33].
    Exp Gerontol. 2018 Jun 2. pii: S0531-5565(18)30330.

    April 2018
  52. KUGA GK, Munoz VR, Gaspar RC, Nakandakari SCBR, et al
    Impaired insulin signaling and spatial learning in middle-aged rats: The role of PTP1B.
    Exp Gerontol. 2018;104:66-71.
    PubMed     Abstract available

    March 2018
  53. KUNUTSOR SK, Laukkanen JA, Burgess S
    Genetically elevated gamma-glutamyltransferase and Alzheimer's disease.
    Exp Gerontol. 2018 Mar 2. pii: S0531-5565(18)30042.
    PubMed     Abstract available

    January 2018
  54. HENRIQUES AD, Benedet AL, Camargos EF, Rosa-Neto P, et al
    Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411.
    PubMed     Abstract available

    December 2017
  55. LE PAGE A, Dupuis G, Frost EH, Larbi A, et al
    Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Exp Gerontol. 2017 Dec 21. pii: S0531-5565(17)30541.
    PubMed     Abstract available

    November 2017
  56. MEREU E, Succa V, Buffa R, Sanna C, et al
    Total body and arm bioimpedance in patients with Alzheimer's disease.
    Exp Gerontol. 2017 Nov 21. pii: S0531-5565(17)30668.
    PubMed     Abstract available

    October 2017
  57. YASHIN AI, Fang F, Kovtun M, Wu D, et al
    Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
    Exp Gerontol. 2017 Oct 26. pii: S0531-5565(17)30424.
    PubMed     Abstract available

  58. MATHYS J, Gholamrezaee M, Henry H, von Gunten A, et al
    Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Exp Gerontol. 2017 Oct 17. pii: S0531-5565(17)30465.
    PubMed     Abstract available

  59. FARINA N, Jerneren F, Turner C, Hart K, et al
    Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Exp Gerontol. 2017 Oct 9. pii: S0531-5565(17)30374.
    PubMed     Abstract available

    August 2017
  60. SCARABINO D, Broggio E, Gambina G, Corbo RM, et al
    Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2017 Aug 18. pii: S0531-5565(17)30445.
    PubMed     Abstract available

    July 2017
  61. CROTEAU E, Castellano CA, Fortier M, Bocti C, et al
    A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Exp Gerontol. 2017 Jul 11. pii: S0531-5565(17)30228.
    PubMed     Abstract available

    May 2017
  62. KWON Y
    Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Exp Gerontol. 2017 May 17. pii: S0531-5565(17)30214.
    PubMed     Abstract available

    March 2017
  63. LI J, Cui X, Ma X, Wang Z, et al
    rBTI reduced beta-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Exp Gerontol. 2017;89:78-86.
    PubMed     Abstract available

    February 2017
  64. HUANG M, Jiang X, Liang Y, Liu Q, et al
    Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Exp Gerontol. 2017;91:25-33.
    PubMed     Abstract available

  65. MACKLIN L, Griffith CM, Cai Y, Rose GM, et al
    Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Exp Gerontol. 2017;88:9-18.
    PubMed     Abstract available

    January 2017
  66. GARD PR, Fidalgo S, Lotter I, Richardson C, et al
    Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Exp Gerontol. 2017 Jan 6. pii: S0531-5565(17)30006.
    PubMed     Abstract available

    December 2016
  67. SCARABINO D, Broggio E, Gambina G, Pelliccia F, et al
    Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimer's disease.
    Exp Gerontol. 2016 Dec 27. pii: S0531-5565(16)30423.
    PubMed     Abstract available

  68. BARRON M, Gartlon J, Dawson LA, Atkinson PJ, et al
    A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.
    Exp Gerontol. 2016 Dec 12. pii: S0531-5565(16)30580.
    PubMed     Abstract available

  69. NAKAGAWA T, Hasegawa Y, Uekawa K, Kim-Mitsuyama S, et al
    Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Exp Gerontol. 2016 Dec 1. pii: S0531-5565(16)30318.
    PubMed     Abstract available

    November 2016
  70. TARANTINI S, Tran CH, Gordon GR, Ungvari Z, et al
    Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
    Exp Gerontol. 2016 Nov 11. pii: S0531-5565(16)30399.
    PubMed     Abstract available

    September 2016
  71. ZHANG ZX, Zhao RP, Wang DS, Wang AN, et al
    Fuzhisan ameliorates Abeta production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Exp Gerontol. 2016;84:88-95.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.